We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

26 hedge funds and large institutions have $8.53M invested in Tonix Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

76% more capital invested

Capital invested by funds: $4.85M → $8.53M (+$3.68M)

7.49% more ownership

Funds ownership: 0.08% → 7.56% (+7.5%)

19% less funds holding

Funds holding: 32 → 26 (-6)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
11
Reduced
1
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.85M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$858K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$692K
4
Millennium Management
Millennium Management
New York
+$690K
5
HF
HRT Financial
New York
+$551K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$548K
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$526K
3
PI
PFG Investments
New York
-$71.9K
4
Two Sigma Investments
Two Sigma Investments
New York
-$66.2K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.64M +$1.85M +91,496 New
BlackRock
2
BlackRock
New York
$1.24M +$215K +10,611 +18%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.11M +$858K +42,318 +215%
Millennium Management
4
Millennium Management
New York
$659K +$690K +34,020 +1,197%
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$610K +$692K +34,153 New
HF
6
HRT Financial
New York
$486K +$551K +27,189 New
CIAM
7
Caitong International Asset Management
Hong Kong
$405K +$459K +22,662 New
State Street
8
State Street
Massachusetts
$358K +$400K +19,722 +5,958%
UBS Group
9
UBS Group
Switzerland
$357K +$46K +2,268 +13%
CIBC Asset Management
10
CIBC Asset Management
Ontario, Canada
$314K +$356K +17,568 New
VF
11
Virtu Financial
New York
$302K +$329K +16,239 +2,541%
EH
12
Equitable Holdings
New York
$268K +$304K +15,000 New
RhumbLine Advisers
13
RhumbLine Advisers
Massachusetts
$244K +$277K +13,670 New
Northern Trust
14
Northern Trust
Illinois
$234K +$166K +8,171 +167%
Bank of America
15
Bank of America
North Carolina
$103K +$116K +5,745 +38,300%
TRCT
16
Tower Research Capital (TRC)
New York
$61.5K +$69.8K +3,441 New
CNBT
17
Cornerstone National Bank & Trust
Illinois
$59.5K +$67.5K +3,330 New
Morgan Stanley
18
Morgan Stanley
New York
$47.9K +$50.6K +2,494 +1,363%
FIA
19
FNY Investment Advisers
New York
$19K +$22.3K +1,100 New
SS
20
SBI Securities
Japan
$4.81K +$4.68K +231 +608%
Osaic Holdings
21
Osaic Holdings
Arizona
$2.27K +$446 +22 +21%
Citigroup
22
Citigroup
New York
$2.18K +$2.47K +122 New
MCI
23
MRP Capital Investments
Georgia
$1.79K – – –
IA
24
IFP Advisors
Florida
$1.52K +$203K +10,000 New
NSIM
25
North Star Investment Management
Illinois
$930 -$20 -1 -2%
1
2

TNXP Hedge Fund Activity: Q1 2025 in Review

26 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2025, worth a combined $8.53M — up 76% from $4.85M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of TNXP and 13 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.85M. The largest seller was Jane Street, exiting entirely with an estimated $548K sold.

  • 26 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q1 2025, down from 32 in Q4 2024.
  • Funds reported $8.53M of Tonix Pharmaceuticals stock for Q1 2025, up 76% quarter-over-quarter.
  • 13 funds opened new Tonix Pharmaceuticals positions in Q1 2025 and 19 closed out, a net change of -6 holders.
  • The largest Tonix Pharmaceuticals buyer in Q1 2025 was Vanguard Group, an estimated $1.85M added.
  • The largest Tonix Pharmaceuticals seller in Q1 2025 was Jane Street, an estimated $548K sold.

Based on aggregated 13F filings for Q1 2025.